Skip to main content
ConductScienceScienceDex
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

12,799

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

12,799 results for “Immunization”

Learn how ShareScore rates datasets ↗
geo12/100

Microarray analysis of genes involved in Streptolysin S immunity

GEO Series GSE48775. Streptococcus pyogenes. 27 samples. Type: Expression profiling by array.

openGEO-OpenSep 2013View details →
geo12/100

The macrophage response to LPS is marked by dynamic nucleosome positioning and increases in nucleosome sensitivity corresponding with immune regulatory factor footprints

GEO Series GSE279622. Homo sapiens. 24 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.

openGEO-OpenFeb 2025View details →
geo12/100

Transcriptomes during monocyte-to-macrophage differentiation and BCG induced trained immunity in vitro

GEO Series GSE262098. Homo sapiens. 21 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenApr 2025View details →
geo12/100

SLC6A3 Dopaminergic Signaling Subverts Spliceosomal Fidelity to Promote Immune Checkpoint Inhibitor Resistance in Clear Cell Renal Cell Carcinoma [1]

GEO Series GSE316468. Mus musculus. 6 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenJan 2026View details →
geo12/100

Zfp335 establishes neonatal immune tolerance through safeguarding effector Treg lineage commitment and maintenance [ChIP-seq]

GEO Series GSE189076. Mus musculus. 2 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.

openGEO-OpenFeb 2022View details →
zenodo12/100

Dataset related to article "Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer."

<p>Colorectal cancer is a major cause of cancer-related death in Western countries and is associated with increased numbers of lymphatic vessels (LV) and tumor-associated macrophages (TAM). The VEGFC/VEGFR3 pathway is regarded as the principal inducer of lymphangiogenesis and it contributes to metastases; however, no data are available regarding its role during primary colorectal cancer development. We found that both VEGFC and VEGFR3 were upregulated in human nonmetastatic colorectal cancer, with VEGFR3 expressed on both LVs and TAMs. With the use of three different preclinical models of colorectal cancer, we also discovered that the VEGFC/VEGFR3 axis can shape both lymphatic endothelial cells and TAMs to synergistically inhibit antitumor immunity and promote primary colorectal cancer growth. Therefore, VEGFR3-directed therapy could be envisioned for the treatment of nonmetastatic colorectal cancer. SIGNIFICANCE: The prolymphangiogenic factor VEGFC is abundant in colorectal cancer and activates VEGFR3 present on cancer-associated macrophages and lymphatic vessels; activation of VEGFR3 signaling fosters cancer immune escape, resulting in enhanced tumor growth.</p>

restrictedMar 2020View details →
zenodo12/100

Data set from the article Massaccesi L, Galliera E, Galimberti D, Fenoglio C, Arcaro M, Goi G, Barassi A, Corsi Romanelli MM. Lag-time in Alzheimer's disease patients: a potential plasmatic oxidative stress marker associated with ApoE4 isoform. Immun Ageing. 2019 Apr 1;16:7. doi: 10.1186/s12979-019-0147-x. PMID: 30984280; PMCID: PMC6444862.

<p>Data set from the article: Massaccesi L, Galliera E, Galimberti D, Fenoglio C, Arcaro M, Goi G, Barassi A, Corsi Romanelli MM. Lag-time in Alzheimer&#39;s disease patients: a potential plasmatic oxidative stress marker associated with ApoE4 isoform. Immun Ageing. 2019 Apr 1;16:7. doi: 10.1186/s12979-019-0147-x. PMID: 30984280; PMCID: PMC6444862.</p> <p>This is the astract:</p> <p>In the brain, Oxidative Stress (OS) contribute to structural and functional changes associated with vascular aging, such as endothelial dysfunction, extracellular matrix degradation, resulting in age-related reduced vasodilatation in response to agonists. For this reason, OS is considered a key factor in Alzheimer&#39;s Disease (AD) development and recent evidence correlated oxidative stress with vascular lesion in the pathogenesis of AD, but the mechanism still need to be fully clarified. The etiology of AD is still not completely understood and is influenced by several factors including Apolipoprotein E (ApoE) genotype. In particular, the Apo &epsilon;4 isoform is considered a risk factor for AD development. This study was aimed to evaluate the possible relationship between three plasmatic OS marker and Apo &epsilon;4 carrier status. Plasmatic soluble receptor for advanced glycation end products (sRAGE) levels, plasma antioxidant total defenses (by lag-time method) and plasmatic Reactive Oxygen species (ROS) levels were evaluated in 25 AD patients and in 30 matched controls. ROS were significantly higher while plasma antioxidant total defenses and sRAGE levels were significantly lower in AD patients compared to controls. In AD patients lag-time values show a significant positive linear correlation with sRAGE levels and a (even not significant) negative correlation with ROS levels. Lag-time is significantly lower in &epsilon;4 carrier (<em>N</em>&nbsp;= 13) than in &epsilon;4 non-carrier (<em>N</em>&nbsp;= 12). Our result confirms the substantial OS in AD. Lag-time levels showed a significant positive correlation with sRAGE levels and a significant association with &epsilon;4 carrier status suggesting that plasmatic lag-time evaluation can be considered as a potential useful OS risk marker in AD.</p> <p>&nbsp;</p>

restrictedMay 2020View details →
zenodo12/100

Plants regulate cellular immunity of caterpillars to an entomovirus

<p>This uploaded file is a dataset for &quot;Plants regulate cellular immunity of caterpillars to an entomovirus&quot;.</p>

restrictedDec 2019View details →
zenodo12/100

Signalling networks govern immune cell avoidance in colorectal cancer

<p>Please refer to https://doi.org/10.5281/zenodo.7015015 instead!</p>

restrictedAug 2020View details →
zenodo12/100

Computational modelling of the cellular interplay in Rheumatoid Arthritis. Deciphering the role of innate and adaptive immunity in cartilage destruction and bone erosion

<p>Immune dysregulation was first implicated in the pathogenesis of Rheumatoid Arthritis (RA) by the discovery of anti-immunoglobulin G (IgG) antibodies known as rheumatoid factors. However, concepts of how immune responses contribute to disease have evolved dramatically over the last 50 years. Many cells and their cytokines play critical roles in the development of RA. The synovial compartment is infiltrated by leukocytes and the synovial fluid is inundated with pro-inflammatory mediators that are produced to induce an inflammatory cascade, which is characterized by interactions of fibroblast-like synoviocytes with the cells of the innate immune system, including monocytes, macrophages, mast cells, dendritic cell as well as cells of adaptive immune system such as T cells and B cells. The fulminant stage contains hyperplastic synovium, cartilage damage, bone erosion, and systemic consequence.</p> <p>The objective of my project is to construct a computational model able to decipher the interplay between cells of the innate and adaptive immunity in RA, that eventually leads to bone and cartilage breakdown.</p> <p>To do so, we will start by creating separate maps for T cells, B cells, macrophages, fibroblasts, osteoblasts and osteoclasts. We will use different data mining tools, appropriate data bases such as KEGG (Kanehisa et al, 2000), REACTOME (Fabregat et al, 2018) as well as internal data generated within Sanofi. We will exploit the graph editor CellDesigner (Funahashi et al, 2003) and the platform Minerva (Gawron et al, 2016) for automatic annotation and reference of the cell specific maps. We will benefit greatly from a global, fully annotated RA specific map (Singh et al, 2018, Singh et al, 2020). This map features interactions implicated in RA coming from various cell types, but due to the extensive annotations the user can opt for cell specific interactions and extract the corresponding network. We are also going to use public datasets of expression data (microarrays, RNAseq, RNAseq single cell), data concerning metabolic pathways from MetaCyc and Sanofi&rsquo;s proprietary datasets to enrich and expand existing pathway resources. These maps will be used to generate cell specific dynamic models using the tool CaSQ (Aghamiri et al, 2020). The next step is the creation of a multicellular model to understand how the different cells interact, contributing to the emergent behavior of the system. We will prioritize signature pathways for each cell type and combine them to build a logical model that will represent the intra- and intercellular relationships.</p> <p>&nbsp;</p>

restrictedNov 2020View details →
zenodo12/100

Link to dataset related to article "Analysis of immune, microbiota and metabolome maturation in infants in a clinical trial of Lactobacillus paracasei CBA L74-fermented formula"

<p>This record contains raw data related to article &ldquo;Analysis of immune, microbiota and metabolome maturation in infants in a clinical trial of Lactobacillus paracasei CBA L74-fermented formula&quot;</p> <p>Mother&#39;s milk is the best choice for infants nutrition, however when it is not available or insufficient to satisfy the needs of the infant, formula is proposed as an effective substitute. Here, we report the results of a randomized controlled clinical trial (<a href="http://clinicaltrials.gov/show/NCT03637894">NCT03637894</a>) designed to evaluate the effects of two different dietary regimens (standard formula and Lactobacillus paracasei CBA L74-fermented formula) versus breastfeeding (reference group) on immune defense mechanisms (primary endpoint: secretory IgA, antimicrobial peptides), the microbiota and its metabolome (secondary outcomes), in healthy full term infants according to the type of delivery (n = 13/group). We show that the fermented formula, safe and well tolerated, induces an increase in secretory IgA (but not in antimicrobial peptides) and reduces the diversity of the microbiota, similarly, but not as much as, breastmilk. Metabolome analysis allowed us to distinguish subjects based on their dietary regimen and mode of delivery. Together, these results suggest that a fermented formula favors the maturation of the immune system, microbiota and metabolome.</p>

restrictedDec 2020View details →
zenodo12/100

Global analyses of human immune variation reveal baseline predictors of postvaccination responses

Open the record for dataset details and reuse information.

restrictedcc-by-4.0Jan 2024View details →
zenodo12/100

Single-cell transcriptomics identifies synergistic role of leukemic and non-leukemic immune repertoires in CD8+ T-cell Large Granular Lymphocytic Leukemia

<p>Data to reproduce findings in the manuscript &quot;Single-cell transcriptomics identifies synergistic role of leukemic and non-leukemic immune repertoires in CD8+ T-cell Large Granular Lymphocytic Leukemia&quot;.&nbsp;<br> <br> The folder contains:</p> <p>1) Processed scRNA+TCRab-seq data in a Seurat-folder, including&nbsp;</p> <p>* Object with 11 T-LGLL samples and 6 healthy samples<br> *&nbsp;Object with only hyperexpanded (&gt;= 10 TCRs) T-cells from&nbsp;all T-LGLL samples and 6 healthy samples<br> * Object with only T-LGLL clones from 11 T-LGLL samples<br> * Object with non-leukemic repertoires from&nbsp;11 T-LGLL samples, 6 healthy samples, 4 CML samples, 4 CLL samples, 2 RCC samples, and 1 NSCLC sample</p> <p><br> 2) TCRb-seq samples from CD8+ sorted peripheral blood samples from patients with&nbsp;CD8+ T-LGLL&nbsp;</p> <p>Please see manuscript and Github for further details.</p>

restrictedDec 2021View details →
zenodo12/100

Dataset related to article "Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors"

<p>This record contains raw data related to article &quot;Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors&quot;</p> <p>Risk factors for hepatic immune-related adverse events (HIRAEs) in patients with advanced/unresectable hepatocellular carcinoma (HCC) treated with immune checkpoint inhibitors (ICIs) are unclear. We investigated: (i) clinical and morpho-pathological predictors of HIRAEs in 27 pretreatment tumor specimens, including surrogate biomarkers of the HCC immune class (based on intratumoral tertiary lymphoid structures, and glutamine synthase, CD3, and CD79 expression); and (ii) the relationship between HIRAE onset and subsequent treatment outcomes. Fifty-eight patients were included-20 (34%) received ICIs alone, and 38 (66%) received ICIs plus targeted agents as first- or further-line treatment. After a median time of 0.9 months (range, 0.4-2.7), nine patients (15.5%) developed grade &ge; 3 hepatitis, which was significantly associated with higher baseline ALT levels (<em>p</em> = 0.037), and an infectious HCC etiology (<em>p</em> = 0.023). ICIs were safely resumed in six out of nine patients. Time to treatment failure (TTF) was not significantly different in patients developing grade &ge; 3 hepatitis vs. lower grades (3.25 vs. 3.91 months, respectively; <em>p</em> = 0.81). Biomarker surrogates for the HCC immune class were not detected in patients developing grade &ge; 3 hepatitis. Grade &ge; 3 hepatitis has a benign course that does not preclude safe ICI reintroduction, without any detrimental effect on TTF.</p>

restrictedJan 2022View details →
zenodo12/100

Dataset related to article "Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity "

<p>This record contains raw data related to article &ldquo;Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity&quot;</p> <p><strong>Background: </strong> Tumor-associated macrophages (TAMs) play a key immunosuppressive role that limits the ability of the immune system to fight cancer and hinder the antitumoral efficacy of most treatments currently applied in the clinic. Previous studies have evaluated the antitumoral immune response triggered by (TLR) agonists, such as poly(I:C), imiquimod (R837) or resiquimod (R848) as monotherapies; however, their combination for the treatment of cancer has not been explored. This study investigates the antitumoral efficacy and the macrophage reprogramming triggered by poly(I:C) combined with R848 or with R837, versus single treatments.</p> <p><strong>Methods: </strong> TLR agonist treatments were evaluated in vitro for toxicity and immunostimulatory activity by Alamar Blue, ELISA and flow cytometry using primary human and murine M-CSF-differentiated macrophages. Cytotoxic activity of TLR-treated macrophages toward cancer cells was evaluated with an in vitro functional assay by flow cytometry. For in vivo experiments, the CMT167 lung cancer model and the MN/MCA1 fibrosarcoma model metastasizing to lungs were used; tumor-infiltrating leukocytes were evaluated by flow cytometry, RT-qPCR, multispectral immunophenotyping, quantitative proteomic experiments, and protein-protein interaction analysis.</p> <p><strong>Results: </strong> Results demonstrated the higher efficacy of poly(I:C) combined with R848 versus single treatments or combined with R837 to polarize macrophages toward M1-like antitumor effectors in vitro. In vivo, the intratumoral synergistic combination of poly(I:C)+R848 significantly prevented tumor growth and metastasis in lung cancer and fibrosarcoma immunocompetent murine models. Regressing tumors showed increased infiltration of macrophages with a higher M1:M2 ratio, recruitment of CD4<sup>+</sup> and CD8<sup>+</sup> T cells, accompanied by a reduction of immunosuppressive CD206<sup>+</sup> TAMs and FOXP3<sup>+</sup>/CD4<sup>+</sup> T cells. The depletion of both CD4<sup>+</sup> and CD8<sup>+</sup> T cells resulted in complete loss of treatment efficacy. Treated mice acquired systemic antitumoral response and resistance to tumor rechallenge mediated by boosted macrophage cytotoxic activity and T-cell proliferation. Proteomic experiments validate the superior activation of innate immunity by poly(I:C)+R848 combination versus single treatments or poly(I:C)+R837, and protein-protein-interaction network analysis reveal the key activation of the STAT1 pathway.</p> <p><strong>Discussion: </strong> These findings demonstrate the antitumor immune responses mediated by macrophage activation on local administration of poly(I:C)+R848 combination and support the intratumoral application of this therapy to patients with solid tumors in the clinic.</p>

restrictedFeb 2022View details →
zenodo12/100

Subjects who have developed SARS-CoV-2 specific IgM-S after vaccination show a longer humoral immunity and a lower frequency of infection

<p>We analysed anti-SARS-CoV-2 spike (S) protein (IgG-S), anti-nucleocapsid IgG (IgG-N) and anti-Spike IgM (IgM-S) in 1872 vaccinees at the first dose (D1; w0), after three weeks at the second dose (D2; w3) at three (w6) and 23 weeks (w29) after D2; 109 subjects where further tested at the booster dose (D3, w44), at three weeks (w47) and six months (w70) after D3. Two-level linear regression models were used to evaluate the differences in IgG-S levels.</p>

restrictedOct 2022View details →
zenodo12/100

Phenotyping Polarization Dynamics Of Immune Cells Using A Lipid Droplet - Cell Pairing Microfluidic Platform

<p>Raw data from the article :&nbsp;</p> <p><strong>Phenotyping Polarization Dynamics Of Immune Cells Using A Lipid Droplet - Cell Pairing Microfluidic Platform</strong></p> <p>L&eacute;a&nbsp;Pinon,&nbsp;Nicolas&nbsp;Ruyssen,&nbsp;Judith&nbsp;Pineau,&nbsp;Olivier&nbsp;Mesdjian,&nbsp;Damien&nbsp;Cuvelier,&nbsp;Rachele&nbsp;Allena,&nbsp;Sophie&nbsp;Asnacios,&nbsp;Atef&nbsp;Asnacios,&nbsp;PaoloPierobon,&nbsp;Jacques&nbsp;Fattaccioli</p>

restrictedOct 2022View details →
zenodo12/100

Epigenetic programming by H3K23ac defines lineage fate of Meg3+ hematopoietic stem cells and drives immune aging (Source Data)

Open the record for dataset details and reuse information.

restrictedcc-by-4.0Jun 2024View details →
zenodo12/100

The mce4D Gene of Mycobacterium tuberculosis Enhances Bacterial Invasion and Suppresses Host Cell Apoptosis to Promote Immune

Open the record for dataset details and reuse information.

restrictedcc-by-4.0Jun 2024View details →
zenodo12/100

VH repertoires from 19 adults immunized with Tdap, at baseline or at day 7

Open the record for dataset details and reuse information.

restrictedcc-by-4.0Jul 2024View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.